Charts Sigyn Therapeutics, Inc.

Stocks

Market Closed - OTC Markets 10:40:15 2026-09-18 EDT			5-day change	1st Jan Change
0.0348 ^USD	-2.79%		-2.79%	-97.96%

05-07	Oragenics signs letter of intent to license Cardiodialysis(TM) technology from Sigyn Therapeutics to target TBI-induced systemic inflammation	RE
05-07	Oragenics Signs Letter of Intent to License CardioDialysis? Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation	CI

Markets		Quality
OTC Markets	SIGY	Delayed

ProRealTime Chart